エンスプリングに関するロシュ社の発表について(甲状腺眼症に対する米国FDA承認)

Chugai Pharmaceutical Co. Ltd. published this content on October 16, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 16, 2026 at 06:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]